Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|November 14, 2020
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumabMaria Reig, Peter R Galle, Masatoshi Kudo, et al.
Journal of Hepatology|February 9, 2022
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysisAmit G Singal, Emily Zhang, Manasa Narasimman, et al.
Oncotarget|April 24, 2018
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinomaAnna Tutusaus, Milica Stefanovic, Loreto Boix, et al.
International Journal of Molecular Sciences|April 13, 2024
Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and MiceIrene Portolés, Jordi Ribera, Esther Fernandez-Galán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of DeathGiuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia, et al.
Liver Cancer|February 28, 2022
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Maria Reig, Ciro Celsa, et al.
Hepatology (Baltimore, Md.)|March 29, 2022
Reliability of extracellular contrast versus gadoxetic acid in assessing small liver lesions using liver imaging reporting and data system v.2018 and European association for the study of the liver criteriaJordi Rimola, Víctor Sapena, Giuseppe Brancatelli, et al.
Frontiers in Immunology|February 23, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Oncotarget|March 22, 2021
Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activityLeonardo G da Fonseca, Carla Fuster-Anglada, Cristina Carrera, et al.
Frontiers in Immunology|June 23, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stagesCarla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Pageof 9